Improve speech through perceptual learning
- Trial ID
- NCT07403539
- Official Title
- Relationship Between Speech Perceptual Learning and Speech Production in Parkinson's Disease
- Goal
- Improve speech through perceptual learning
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- State University of New York at Buffalo
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- Parkinson's Disease
- Interventions
- Intensity learning, Intensity discrimination, Rate learning, Rate discrimination
Plain-Language Summary
The goal is to see whether sharpening how people with Parkinson's hear loudness and speaking rate can help them speak louder, clearer, or at a more natural speed. Participants do listening-based training that teaches intensity discrimination and rate discrimination, essentially practice detecting small changes in loudness and speech rate so they can adjust their own production; these are behavioral exercises rather than drugs, and people stay on their usual levodopa. The study is enrolling U.S. residents age 45 and up with Parkinson's who are native North American English speakers and take a levodopa-containing medication, excluding those with other major neurological problems, prior non-Parkinson's speech or language disorders, or significant hearing loss.
Locations
- State University of New York at Buffalo, Buffalo, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Intensity learning. The goal is to see whether sharpening how people with Parkinson's hear loudness and speaking rate can help them speak louder, clearer, or at a more natural speed. Participants do listening-based training that teaches intensity discrimination and rate discrimination, essentially practice detecting small changes in loudness and speech rate so they can adjust their own production; these are behavioral exercises rather than drugs, and people stay on their usual levodopa. The study is enrolling U.S. residents age 45 and up with Parkinson's who are native North American English speakers and take a levodopa-containing medication, excluding those with other major neurological problems, prior non-Parkinson's speech or language disorders, or significant hearing loss.
- Who can participate?
- Participants must be at least 45 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.